Kiniksa Pharmaceuticals International, plc KNSA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's gross profit?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported gross profit of $193.47M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's gross profit changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's gross profit increased by 61.3% year-over-year, from $119.92M to $193.47M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's gross profit?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's gross profit has grown at a 112.5% compound annual growth rate (CAGR), from $29.44M to $599.89M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.